LV12493B - PHARMACEUTICAL COMPOSITION CONTAINING PLASMA BLOOD - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING PLASMA BLOOD Download PDF

Info

Publication number
LV12493B
LV12493B LVP-00-38A LV000038A LV12493B LV 12493 B LV12493 B LV 12493B LV 000038 A LV000038 A LV 000038A LV 12493 B LV12493 B LV 12493B
Authority
LV
Latvia
Prior art keywords
water
product
serum albumin
protein fraction
solution
Prior art date
Application number
LVP-00-38A
Other languages
English (en)
Latvian (lv)
Other versions
LV12493A (en
Inventor
Lajos HEGED�S
Krisztina Krempels
Krisztina Paal
Gabor PETH�
Original Assignee
Human Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Rt. filed Critical Human Rt.
Publication of LV12493A publication Critical patent/LV12493A/xx
Publication of LV12493B publication Critical patent/LV12493B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LVP-00-38A 1997-09-18 2000-03-14 PHARMACEUTICAL COMPOSITION CONTAINING PLASMA BLOOD LV12493B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9701554A HUP9701554D0 (en) 1997-09-18 1997-09-18 Pharmaceutical composition containing plazma proteins
PCT/HU1998/000086 WO1999013914A1 (en) 1997-09-18 1998-09-17 Pharmaceutical compositions containing plasma protein

Publications (2)

Publication Number Publication Date
LV12493A LV12493A (en) 2000-06-20
LV12493B true LV12493B (en) 2001-01-20

Family

ID=90014222

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-00-38A LV12493B (en) 1997-09-18 2000-03-14 PHARMACEUTICAL COMPOSITION CONTAINING PLASMA BLOOD

Country Status (33)

Country Link
US (5) US6743826B1 (de)
EP (1) EP0981375B1 (de)
JP (1) JP2001508806A (de)
KR (1) KR100587962B1 (de)
CN (1) CN1189216C (de)
AR (1) AR017120A1 (de)
AT (1) ATE230611T1 (de)
AU (1) AU734695B2 (de)
BG (1) BG64749B1 (de)
BR (1) BR9812469A (de)
CA (1) CA2269923C (de)
CZ (1) CZ301326B6 (de)
DE (1) DE69810612T2 (de)
DK (1) DK0981375T3 (de)
EA (1) EA004700B1 (de)
ES (1) ES2187062T3 (de)
HR (1) HRP980499A2 (de)
HU (1) HUP9701554D0 (de)
IL (1) IL135055A (de)
LT (1) LT4736B (de)
LV (1) LV12493B (de)
NO (1) NO325294B1 (de)
NZ (1) NZ503302A (de)
PL (1) PL193067B1 (de)
PT (1) PT981375E (de)
RO (1) RO118695B1 (de)
RS (1) RS50102B (de)
SI (1) SI20189B (de)
SK (1) SK284683B6 (de)
TR (1) TR200001545T2 (de)
TW (1) TWI222365B (de)
WO (1) WO1999013914A1 (de)
ZA (1) ZA988585B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US8137684B2 (en) * 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
WO2000047187A1 (en) * 1999-02-11 2000-08-17 Kinetana Inc. Serum albumin-based parenteral formulations of polyene macrolides
KR100757909B1 (ko) 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ivf를 위한 조성물
WO2001076559A1 (en) * 2000-04-10 2001-10-18 Teva Pharmaceutical Industries Ltd. Method 0f administration of paclitaxel-plasma protein formulation
SK14452002A3 (sk) * 2000-04-10 2003-07-01 Teva Pharmaceutical Industries Ltd. Liečivo na liečenie rakoviny
CA2445763A1 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
EP2261250B1 (de) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin Fusionsproteine
GR1004274B (el) 2002-07-16 2003-06-23 Medexis ���� Συμπλοκα στεροειδων ορμονων με πρωτεινες: νεες ουσιες για την ειδικη ανιχνευση και καταστροφη καρκινικων κυτταρων προερχομενων απο στερεους ογκους και αιματολογικες κακοηθειες
MXPA05000615A (es) 2002-07-16 2005-11-17 Medexis S A Conjugados esteroideos, preparacion de los mismos y usos de los mismos.
WO2004024188A1 (ja) * 2002-09-12 2004-03-25 Nihon Medi-Physics Co., Ltd. 薬物の血漿蛋白質結合を制御するための製剤
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
WO2004101620A2 (en) * 2003-05-01 2004-11-25 Compound Therapeutics, Inc. Serum albumin scaffold-based proteins and uses thereof
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20050277584A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
WO2006035443A2 (en) * 2004-09-29 2006-04-06 Tel Hashomer Medical Research Infrastructure And Services Ltd. Monitoring of convection enhanced drug delivery
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
JP2010527285A (ja) 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
WO2009116557A1 (ja) * 2008-03-21 2009-09-24 富士フイルム株式会社 薬剤含有組成物
CN101658516B (zh) * 2008-08-26 2011-10-05 齐鲁制药有限公司 紫杉醇类药物组合物及其制备方法
EP3300723A1 (de) 2009-05-18 2018-04-04 Sigmoid Pharma Limited Zusammensetzung mit oltropfen
JP5911799B2 (ja) 2009-08-12 2016-04-27 シグモイド・ファーマ・リミテッドSigmoid Pharma Limited ポリマーマトリックスおよび油相を含んで成る免疫調節組成物
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
RU2589697C2 (ru) * 2009-12-18 2016-07-10 Экзодос Лайф Сайенсиз Лимитед Партнершип Способы получения стабильных жидких лекарственных препаратов и их композиции
WO2011097149A2 (en) * 2010-02-03 2011-08-11 Oncbiomune, L.L.C. Taxane-and taxoid-protein compositions
AR093275A1 (es) 2010-03-17 2015-05-27 Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2015140736A1 (en) 2014-03-18 2015-09-24 Izun Pharmaceuticals Corp. Protein-bound cannabinoid compositions
EP3215127B1 (de) 2014-11-07 2020-10-28 Sublimity Therapeutics Limited Cyclosporin enthaltende zusammensetzungen
AR100034A1 (es) 2015-01-30 2016-09-07 Consejo Nac De Investig Científicas Y Técnicas (Conicet) Una composición farmacéutica soluble en agua que comprende, al menos, una sustancia terapéuticamente activa y, al menos, una sustancia con capacidad para formar micelas
US10071141B2 (en) 2015-05-08 2018-09-11 Spectral Platforms, Inc. Albumin-based non-covalent complexes and methods of use thereof
WO2016187147A1 (en) * 2015-05-15 2016-11-24 Fl Therapeutics Llc Docetaxel and human serum albumin complexes
WO2016205654A1 (en) * 2015-06-18 2016-12-22 Aquarius Biotechnologies, Inc. Compositions and methods for treating inflammatory disease or conditions
WO2017083397A1 (en) * 2015-11-09 2017-05-18 Cayo Max A Cardiac glycosides for the treatment of hypercholesterolemia
US20190175702A1 (en) * 2016-08-03 2019-06-13 Zhuhai Beihai Biotech Co., Ltd. Formulations of fosaprepitant and aprepitant
WO2018081520A1 (en) 2016-10-27 2018-05-03 Zhuhai Beihai Biotech Co., Ltd. Neutral ph compositions of docetaxel and human serum albumin
WO2018175346A1 (en) 2017-03-20 2018-09-27 Spectral Platforms, Inc. Spectroscopic methods to detect and characterize microorganisms
US11744859B2 (en) 2017-07-07 2023-09-05 Epicentrx, Inc. Compositions and methods for parenteral administration of therapeutic agents
MX2020009235A (es) * 2018-03-09 2023-01-16 Kiora Pharmaceuticals Gmbh Formulacion oftalmica.
EP3811982A1 (de) * 2019-10-25 2021-04-28 Université de Strasbourg Biomaterial auf proteinbasis mit viskoelastischem verhalten, verfahren zur herstellung davon und verwendungen davon
CN111529506B (zh) * 2020-05-18 2021-09-03 同济大学 一种两性霉素b白蛋白纳米制剂及其制备方法和应用
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN114544926A (zh) * 2021-12-02 2022-05-27 浙江鑫科医疗科技有限公司 一种血清蛋白稳定剂
CN115236216B (zh) * 2022-06-07 2024-03-01 合肥和合医疗科技有限公司 高效液相色谱串联质谱检测全血中免疫抑制剂的试剂盒,其制备方法和检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4833013A (de) * 1971-08-30 1973-05-07
DE2653534C2 (de) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung
JPS58216126A (ja) * 1982-06-11 1983-12-15 Ono Pharmaceut Co Ltd 可容化製剤
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
WO1988006457A1 (en) * 1987-03-04 1988-09-07 Nippon Hypox Laboratories Incorporated Medicinal composition containing albumin as carrier and process for its preparation
JPS63215640A (ja) * 1987-03-04 1988-09-08 Nippon Hai Potsukusu:Kk 易吸収性抗炎症剤及びその製造方法
CA2086874E (en) 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
US5356927A (en) * 1992-12-02 1994-10-18 Thomas Jefferson University Methods of treating plasmodium and babesia parasitic infections
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
GB9510716D0 (en) * 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
TR199600775A2 (tr) 1996-09-27 1997-09-21 Tureks Turunc Madencilik Ic Ve Taslara eskitilmis görüntü kazandirilmasi icin bir yöntem.
US5776912A (en) * 1996-12-20 1998-07-07 Schering Corporation Lipophilic oligosaccharide antibiotic compositions
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
ITMI20001107A1 (it) * 2000-05-18 2001-11-18 Acs Dobfar Spa Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel

Also Published As

Publication number Publication date
WO1999013914A1 (en) 1999-03-25
US20100076008A1 (en) 2010-03-25
BR9812469A (pt) 2002-02-05
JP2001508806A (ja) 2001-07-03
IL135055A (en) 2004-09-27
YU16600A (sh) 2003-08-29
EA004700B1 (ru) 2004-06-24
NO325294B1 (no) 2008-03-17
CA2269923A1 (en) 1999-03-25
CZ301326B6 (cs) 2010-01-20
CZ2000952A3 (cs) 2000-09-13
TWI222365B (en) 2004-10-21
SI20189A (sl) 2000-10-31
EP0981375A1 (de) 2000-03-01
AU734695B2 (en) 2001-06-21
ZA988585B (en) 2000-03-13
US20070232536A1 (en) 2007-10-04
NO20001371D0 (no) 2000-03-16
KR20010052072A (ko) 2001-06-25
US7119124B2 (en) 2006-10-10
RO118695B1 (ro) 2003-09-30
LT4736B (lt) 2000-12-27
PL339369A1 (en) 2000-12-18
LV12493A (en) 2000-06-20
NO20001371L (no) 2000-05-18
US20040014655A1 (en) 2004-01-22
AR017120A1 (es) 2001-08-22
US20050064028A1 (en) 2005-03-24
LT2000018A (en) 2000-08-25
PL193067B1 (pl) 2007-01-31
BG104245A (en) 2000-11-30
DK0981375T3 (da) 2003-05-05
CA2269923C (en) 2003-07-22
HUP9701554D0 (en) 1997-11-28
SK284683B6 (sk) 2005-09-08
US8946167B2 (en) 2015-02-03
ES2187062T3 (es) 2003-05-16
NZ503302A (en) 2001-08-31
HRP980499A2 (en) 1999-12-31
SK3292000A3 (en) 2000-08-14
PT981375E (pt) 2003-04-30
ATE230611T1 (de) 2003-01-15
EA200000331A1 (ru) 2000-10-30
BG64749B1 (bg) 2006-02-28
CN1270529A (zh) 2000-10-18
KR100587962B1 (ko) 2006-06-13
IL135055A0 (en) 2001-05-20
DE69810612T2 (de) 2003-10-02
DE69810612D1 (de) 2003-02-13
RS50102B (sr) 2009-01-22
AU9362398A (en) 1999-04-05
SI20189B (sl) 2007-10-31
US7501455B2 (en) 2009-03-10
CN1189216C (zh) 2005-02-16
US6743826B1 (en) 2004-06-01
EP0981375B1 (de) 2003-01-08
TR200001545T2 (tr) 2000-10-23

Similar Documents

Publication Publication Date Title
LV12493B (en) PHARMACEUTICAL COMPOSITION CONTAINING PLASMA BLOOD
Zhao et al. A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity
JP2001524990A (ja) リポソームに封入されたタキサンの投与方法
US20120039983A1 (en) Amphiphilic macromolecule-lipid complexes
JPH09512261A (ja) タキサン系の誘導体に基づく製薬組成物
JP2021181492A (ja) 高分子化薬物含有医薬組成物
EP1701699B1 (de) Pharmazeutische Zusammensetzungen eines A2a Rezeptorantagonisten
KR20220045203A (ko) 암 치료에 따른 화학요법-유도된 말초 신경병증 치료를 위한 palm
HU223974B1 (hu) Plazma protein tartalmú gyógyszerkészítmények és eljárás előállításukra
MXPA00002561A (en) Pharmaceutical compositions containing plasma protein
WO2005017079A1 (en) Process for the purification of non-ionic solvants for stabilized injectable pharmaceutical formulaitons